| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/29/1999 | US5916578 Lipid composition containing a liquid crystal phase |
| 06/29/1999 | US5916556 Human MRNA editing enzyme |
| 06/29/1999 | US5916371 Crystalline powdery saccsharide, its preparation and uses |
| 06/24/1999 | WO1999031233A1 Polypeptides, polynucleotides and uses thereof |
| 06/24/1999 | WO1999031141A2 Method for producing regular porous cellulose pearls, corresponding cellulose pearls and use thereof |
| 06/24/1999 | WO1999031125A1 Wound healing compositions |
| 06/24/1999 | WO1999031099A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999031090A1 Dihydrobenzofurans |
| 06/24/1999 | WO1999031066A1 Pyridones as src family sh2 domain inhibitors |
| 06/24/1999 | WO1999031061A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030729A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 06/24/1999 | WO1999030713A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030682A1 Novel antioxidant mixture |
| 06/24/1999 | WO1999030675A1 Methods for improving the health of hair and scalp |
| 06/24/1999 | WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 06/24/1999 | WO1999030562A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation |
| 06/24/1999 | WO1999018919A3 Topical compositions for regulating the oily/shiny appearance of skin |
| 06/24/1999 | CA2315232A1 Integrin receptor antagonists |
| 06/24/1999 | CA2314899A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 06/24/1999 | CA2314111A1 Dihydrobenzofurans |
| 06/24/1999 | CA2281650A1 Methods for improving the health of hair and scalp |
| 06/23/1999 | EP0924201A1 Tricyclic-substituted pyrazolyl benzenesulfonamides and their use as cyclooxygenase II inhibitors |
| 06/23/1999 | EP0923937A2 A herbal formulation useful as a therapeutic and cosmetic application for the treatment of general skin disorders |
| 06/23/1999 | EP0923933A1 Substituted pyrazolyl benzenesulfonamides for use in the treatment of inflammation |
| 06/23/1999 | EP0923585A1 Phosphinate based inhibitors of matrix metalloproteases |
| 06/23/1999 | EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives |
| 06/23/1999 | EP0923563A1 1,4-heterocyclic metallprotease inhibitors |
| 06/23/1999 | EP0923561A1 Heterocyclic metalloprotease inhibitors |
| 06/23/1999 | EP0923547A1 Bidentate metalloprotease inhibitors |
| 06/23/1999 | EP0923546A1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2 |
| 06/23/1999 | EP0923378A1 Promotion of wound healing by chemically-modified tetracyclines |
| 06/23/1999 | EP0923366A1 Sunscreen compositions containing damaged rna fragments |
| 06/23/1999 | EP0814660B1 Topical antimicrobial agents |
| 06/23/1999 | CN1220605A Nucleotide analogues for topical treatment of proliferative disease of skin |
| 06/23/1999 | CN1220266A Intermediates of protein kinase C inhibitors and preparation process thereof |
| 06/22/1999 | US5914406 Azepanes and their ring homologues having protein kinase inhibiting activity |
| 06/22/1999 | US5914347 By adding to a hydroxyalkyl cellulose, evaporating the solution or dispersion to dryness under an inert atmosphere to prepare a powder; imparts oxidation resistance |
| 06/22/1999 | US5914314 Hyaluronic acid and its nontoxic salts facilitate penetration of immunosuppressent through underperfused or pathological tissue, including scar tissue |
| 06/22/1999 | US5914300 Mild antimicrobial liquid cleansing formulations comprising hydroxy acid buffering compound or compounds as potentiator of antimicrobial effectiveness |
| 06/22/1999 | US5914118 Multi-layered drug containing film preparation having powder adhesive thereon |
| 06/22/1999 | US5914111 Inhibiting t-cell activation by administering polypeptide having amino acids 1-92 of lymphocyte functioning associated antigen-3 joined to different protein or polypeptide comprising portion of immunoglobulin |
| 06/22/1999 | US5913884 Inhibition of fibrosis by photodynamic therapy |
| 06/22/1999 | CA2151674C Methods of administering crf antagonists |
| 06/17/1999 | WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | WO1999029856A1 Restin and methods of use thereof |
| 06/17/1999 | WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | WO1999029726A1 Phospholipase inhibitor |
| 06/17/1999 | WO1999029693A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 06/17/1999 | WO1999029674A1 Retinoic acid mimetic anilides |
| 06/17/1999 | WO1999029667A1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 06/17/1999 | WO1999029339A2 Prevention and/or treatment of allergic conditions |
| 06/17/1999 | WO1999029294A1 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners |
| 06/17/1999 | WO1999029293A1 Compositions comprising a combination of a free sphingoid base and a ceramide and uses thereof |
| 06/17/1999 | WO1999029292A1 Use of carboxylic acid to stabilize or improve epidermal synthesized ceramide |
| 06/17/1999 | WO1999029291A1 Oil-in-water emulsions containing a 1,3,5-triazine derivative and a copolyol silicone and cosmetic applications |
| 06/17/1999 | WO1998055075A3 Compositions and methods for inhibiting photoaging of skin |
| 06/17/1999 | CA2313705A1 Restin and methods of use thereof |
| 06/17/1999 | CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | CA2312720A1 Retinoic acid mimetic anilides |
| 06/17/1999 | CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | CA2311722A1 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners |
| 06/17/1999 | CA2279401A1 Oil-in-water emulsions containing a 1,3,5-triazine derivative and a copolyol silicone and cosmetic applications |
| 06/16/1999 | EP0922697A1 Substituted Pyrazolyl benzenesulfonamides and their use as cyclooxygenase II inhibitors |
| 06/16/1999 | EP0922456A1 Skin rash prevention composition |
| 06/16/1999 | EP0922452A1 Skin care composition |
| 06/16/1999 | EP0922111A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
| 06/16/1999 | EP0922105A2 Infectious papillomavirus pseudoviral particles |
| 06/16/1999 | EP0922030A1 Arylsulfonylamino hydroxamic acid derivatives |
| 06/16/1999 | EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 06/16/1999 | EP0921806A1 Mannose-6-phosphate composition and its use in treating fibrotic disorders |
| 06/16/1999 | EP0921791A1 Composition comprising mupirocin and chlorhexidine |
| 06/16/1999 | EP0921785A1 Combination of acid protease enzymes and acidic buffers and uses thereof |
| 06/16/1999 | EP0633764B1 Skin care method and composition |
| 06/16/1999 | CN1219935A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 06/16/1999 | CN1219928A Novel vitamin D analogues |
| 06/16/1999 | CN1219880A Acne treatment |
| 06/16/1999 | CN1219871A Method of regulating skin appearance with vitamin B3 compound |
| 06/16/1999 | CN1219409A Traditional Chinese medicine for curing psoriasis |
| 06/16/1999 | CN1219401A Seahorse pain-eliminating ointment |
| 06/16/1999 | CN1219394A Fenciping (suppressing of comedo) for cosmetics and health-care |
| 06/16/1999 | CN1219387A Yajie cosmetic face-washing powder |
| 06/15/1999 | US5912357 Enzyme inhibitors |
| 06/15/1999 | US5912346 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 06/15/1999 | US5912270 Anti-inflammatory compounds |
| 06/15/1999 | US5912152 Process for preparing sphingomyelin and ceramide from erythrocyte as a starting material and a curing agent or cosmetic formulated with ceramide |
| 06/15/1999 | US5912010 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 06/15/1999 | CA2151888C Topical composition containing an antioxidant and a bacterial extract; use thereof |
| 06/10/1999 | WO1999028359A1 Preparation for prevention and healing of inflammation affections |
| 06/10/1999 | WO1999028335A1 Secreted proteins and polynucleotides encoding them |
| 06/10/1999 | WO1999028310A1 Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride |
| 06/10/1999 | WO1999027962A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation |
| 06/10/1999 | WO1999027927A1 Synergistic antimicrobial compositions |
| 06/10/1999 | WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 06/10/1999 | WO1999027793A2 An antimicrobial composition |
| 06/10/1999 | WO1998040080A9 Oxyalkylene phosphate compounds and uses thereof |
| 06/10/1999 | DE19754659A1 Verwendung von Kohlensäure zur Stabilisierung oder Erhöhung der epidermalen Ceramidsyntheserate Use of carbon dioxide for stabilizing or increasing the epidermal ceramide synthesis |
| 06/10/1999 | DE19753383A1 Verwendung von Abciximab zur Behandlung von Mikrozirkulationsstörungen Use of abciximab for treatment of microcirculatory disorders |
| 06/10/1999 | CA2312824A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation |
| 06/10/1999 | CA2312811A1 Synergistic antimicrobial compositions |
| 06/10/1999 | CA2312290A1 Secreted proteins and polynucleotides encoding them |